UNSPSC 51392212: Piroximone

This classification denotes a phosphodiesterase inhibitor with the molecular formula C11H11N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2VSD0380YB, chemically known as 2h-imidazol-2-one, 4-ethyl-1,3-dihydro-5-(4-pyridinylcarbonyl)- but generally known as piroximone, which bears US NIH Compound Identifier 55263. European Medicines Agency schedules Piroximone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09938MIG. The term PIROXIMONE is an International Non-Proprietary Name.

UNSPSC 51392212 Piroximone, a Commodity code, does not describe the work actually being solicited under recent state and local opportunities tagged to it. The two recent opportunities in the source — Seminole County, Florida's procurement of naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription programs — involve naloxone procurement and pharmacy benefit program design, neither of which falls within the scope of piroximone (a cardioprotective pharmaceutical compound). The mismatch between the code's nominal scope and actual recent solicitations indicates that state and local governments show little relevant recent activity under this Commodity code as currently tagged in public procurement records.

No additional issuing bodies, geographic spread, or representative opportunities exist in the source that align with piroximone procurement itself. The code appears inactive or incorrectly applied in current state and local procurement activity.